LFTClass II
Fluorescent Immunoassay, Primidone
21 CFR 862.3680 / Clinical Toxicology
LFT is the FDA product code for Fluorescent Immunoassay, Primidone, a class II device type, regulated under 21 CFR 862.3680. As of , FDA records hold 8 510(k) clearances under this code, the most recent dated , and no recalls.
Classification record
- Product code
- LFT
- Device name
- Fluorescent Immunoassay, Primidone
- Regulation
- 21 CFR 862.3680
- Device class
- Class II
- Review panel
- Clinical Toxicology
- Submission type
- 510(k)
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- Yes
- Ingested clearances
- 8
- Ingested recalls
- 0
Clearances, product code LFT
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 1981 | 1 |
| 1982 | 1 |
| 1983 | 1 |
| 1984 | 1 |
| 1985 | 1 |
| 1989 | 1 |
| 1990 | 1 |
| 1995 | 1 |
Applicants with the most clearances
Product code LFT| Applicant | Clearances |
|---|---|
| American Dade | 1 |
| American Diagnostic Corp. | 1 |
| Baxter Healthcare Corporation | 1 |
| Miles Laboratories, Inc. | 1 |
| Roche Diagnostic Systems, Inc. | 1 |
| Sigma Diagnostics, Inc. | 1 |
| Syva Co. | 1 |
| Tudor Laboratories, Inc. | 1 |
Companies listing this code with FDA
Companies whose registered establishments list this codeFIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
